Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.95
-1.08 (-9.79%)
At close: May 18, 2026, 4:00 PM EDT
10.54
+0.59 (5.93%)
After-hours: May 18, 2026, 4:51 PM EDT
CRBP Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, CRBP stock has a consensus rating of "Strong Buy" and an average price target of $38.4. The average 1-year stock price forecast is 285.93% higher than the current stock price, while the lowest is $17 (+70.85%) and the highest is $54 (+442.71%).
Price Target: $38.4 (+285.93%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CRBP stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $36 → $33 | Strong Buy | Maintains | $36 → $33 | +231.66% | May 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $57 → $54 | Buy | Maintains | $57 → $54 | +442.71% | May 13, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +352.26% | May 13, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +352.26% | Apr 29, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $53 → $57 | Buy | Maintains | $53 → $57 | +472.86% | Mar 10, 2026 |
Financial Forecast
Revenue This Year
1.70M
Revenue Next Year
3.67M
from 1.70M
Increased by 116.00%
EPS This Year
-4.57
from -5.90
EPS Next Year
-4.94
from -4.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 10.5M | 21.0M | ||||||
| Avg | 1.7M | 3.7M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 1,135.3% | ||||||
| Avg | - | 116.0% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.26 | -2.45 | ||||||
| Avg | -4.57 | -4.94 | ||||||
| Low | -5.63 | -7.83 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.